ALK and glioblastoma: MDK was also shown to increase GBM cell proliferation, migration, and invasion and induce temozolomide resistance by improving the stem-like properties of GBM through ALK and Notch homolog 1 (Notch1)/phosphorylated c-Jun N-terminal kinase (p-JNK) signaling pathways16,22,31.